Foresight Biotherapeutics is a drug development firm that develops therapies for ophthalmology and otolaryngology.
Business Model: Non-Profit
Revenue: $13.1M
Employees: 51-200
Foresight Biotherapeutics was acquired by
Shire.
The acquisition happend on 2015-08-03.
Details of the transaction were not public
Address: 50 W 57th St
City: New York
State: NY
Zip: 10019
Country: US
Foresight Biotherapeutics is a drug development firm that develops therapies for ophthalmology and otolaryngology.
Contact Phone:
+16467479100
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 11/2013 | Venture Round | 1 | $15M |
Integrin Partners Integrin Partners Integrin Partners Integrin Partners |
10/2013 | Equity | $15M |
Integrin Partners, LLC |
7/2011 | Seed Round | $2M |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|